BAM
BIIB icon

Bellevue Asset Management’s Biogen BIIB Stock Holding History

Bellevue Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-65
Closed -$18K – 593
2021
Q1 		$18K Hold
65
– – 0.01% 296
2020
Q4 		$18K Hold
65
– – 0.01% 289
2020
Q3 		$18K Buy
65
+22
+51% +$6.14K 0.01% 267
2020
Q2 		$12K Hold
43
– – 0.01% 316
2020
Q1 		$13K Buy
43
+5
+13% +$1.52K 0.01% 308
2019
Q4 		$11K Buy
+38
New +$10.5K 0.01% 298

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bellevue Asset Management's BIIB Position: Q2 2021 in Review

Bellevue Asset Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 65 shares — an estimated $18K sold.

Bellevue Asset Management first reported a position in BIIB in Q4 2019 and held it in 6 quarters. The position peaked at $18K in Q1 2021. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Bellevue Asset Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Bellevue Asset Management sold 65 Biogen shares in Q2 2021, an estimated $18K.
  • Bellevue Asset Management first reported a position in Biogen in Q4 2019 and held it in 6 quarters.
  • Bellevue Asset Management's Biogen position peaked at $18K in Q1 2021.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Bellevue Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.